v3.25.1
Investments and Fair Value Measurement
 3 Months Ended
Mar. 31, 2025
Fair Value Disclosures [Abstract]  
Investments and Fair Value Measurement
Note 2 – Investments and Fair Value Measurement
Investments
Our investments on the condensed consolidated balance sheets consisted of the following (in millions):
As of
December 31, 2024March 31, 2025
Classified as short-term investments:
Marketable debt securities (1):
U.S. government and agency securities$167 $192 
Commercial paper220 121 
Corporate bonds659 535 
Certificates of deposit38 46 
Short-term investments$1,084 $894 
Classified as restricted investments:
Marketable debt securities (1):
U.S. government and agency securities$5,552 $5,920 
Commercial paper179 89 
Corporate bonds1,288 1,362 
Restricted investments$7,019 $7,371 
Classified as investments:
Non-marketable equity securities:
Didi$2,602 $2,757 
Other (2)
608 814 
Marketable equity securities:
Grab2,529 2,428 
Aurora (3)
2,054 2,191 
Other523 412 
Note receivable from a related party (2)
144 144 
Investments$8,460 $8,746 
(1) Excluding marketable debt securities classified as cash equivalents and restricted cash equivalents.
(2) These balances include certain investments recorded at fair value with changes in fair value recorded in earnings due to the election of the fair value option of accounting for financial instruments.
(3) In connection with Aurora’s November 2021 initial public offering, we are subject to a lock-up agreement in which our ability to sell or transfer our shares in Aurora is partially restricted until November 2025.
Assets Measured at Fair Value on a Recurring Basis
The following table presents our financial assets measured at fair value on a recurring basis based on the three-tier fair value hierarchy (in millions):
As of December 31, 2024As of March 31, 2025
Level 1Level 2Level 3TotalLevel 1Level 2Level 3Total
Financial Assets
Money market funds$1,868 $— $— $1,868 $734 $— $— $734 
U.S. government and agency securities— 5,848 — 5,848 — 6,153 — 6,153 
Commercial paper— 702 — 702 — 289 — 289 
Corporate bonds— 1,974 — 1,974 — 1,901 — 1,901 
Certificates of deposit— 38 — 38 — 46 — 46 
Non-marketable equity securities— — 11 11 — — 6 6 
Marketable equity securities5,106 — — 5,106 5,031 — — 5,031 
Note receivable from a related party— — 144 144 — — 144 144 
Total financial assets$6,974 $8,562 $155 $15,691 $5,765 $8,389 $150 $14,304 
During the three months ended March 31, 2025, we did not make any transfers into or out of Level 3 of the fair value hierarchy.
Debt Securities
The following table summarizes the amortized cost, unrealized gains and losses, and fair value of our debt securities (in millions):
 As of December 31, 2024As of March 31, 2025
 Amortized CostUnrealized GainsUnrealized LossesFair ValueAmortized CostUnrealized GainsUnrealized LossesFair Value
U.S. government and agency securities$5,843 $7 $(2)$5,848 $6,148 $6 $(1)$6,153 
Commercial paper702 — — 702 289 — — 289 
Corporate bonds1,975 1 (2)1,974 1,901 1 (1)1,901 
Certificates of deposit38 — — 38 46 — — 46 
Total$8,558 $8 $(4)$8,562 $8,384 $7 $(2)$8,389 
As of December 31, 2024 and March 31, 2025, there were no allowance for credit losses related to our debt securities. The weighted-average remaining maturity of our debt securities was less than one year as of March 31, 2025.
Derivatives Not Designated as Hedging Instruments
We enter into financial derivative instruments, consisting of foreign currency contracts to mitigate the foreign currency exchange risk of our assets and liabilities denominated in currencies other than the functional currency. We do not use derivatives for trading or speculative purposes. These instruments are recorded on the condensed consolidated balance sheets at fair value and classified within Level 2 of the fair value hierarchy. Gains and losses on the derivative instruments that are not designated as hedging instruments are recognized in other income (expense), net in the condensed consolidated statements of operations. The cash flows associated with our non-designated derivatives are classified in cash flows from investing activities on our condensed consolidated statements of cash flows.
As of March 31, 2025, the fair value of our outstanding derivative assets and liabilities were not material. We did not record any material realized or unrealized gains or losses for our financial derivative instruments during the three months ended March 31, 2025.
We have master netting arrangements with certain counterparties to our foreign currency exchange contracts, which are designed to reduce credit risk by permitting net settlement of transactions with the same counterparty. We have elected to present the derivative assets and derivative liabilities on a gross basis on our condensed consolidated balance sheets. As of March 31, 2025, there were no rights of set-off associated with our foreign currency exchange contracts.
The total notional amount of outstanding derivatives not designated as hedging instruments was $1.9 billion as of March 31, 2025.
Assets Measured at Fair Value on a Non-Recurring Basis
Non-Marketable Equity Securities
Our non-marketable equity securities are investments in privately held companies without readily determinable fair values. The
carrying value of our non-marketable equity securities are adjusted based on price changes from observable transactions of identical or similar securities of the same issuer (referred to as the measurement alternative) or for impairment. Any changes in carrying value are recorded within other income (expense), net in the condensed consolidated statements of operations. Certain non-marketable equity securities are classified within Level 3 in the fair value hierarchy because we estimate the fair value of these securities based on valuation methods, including the common stock equivalent (“CSE”) method and option-pricing model (“OPM”), using the transaction price of similar securities issued by the investee adjusted for contractual rights and obligations of the securities we hold.
The following table summarizes the total carrying value of our non-marketable equity securities measured at fair value on a non-recurring basis held, including cumulative unrealized upward and downward adjustments made to the initial cost basis of the securities (in millions):
As of
December 31, 2024March 31, 2025
Initial cost basis$2,030 $2,239 
Upward adjustments2,611 2,767 
Downward adjustments (including impairment)(1,442)(1,441)
Total carrying value at the end of the period$3,199 $3,565 
Didi Investment
We measure the fair value of our Didi investment based on the closing share price of the Didi American Depositary Shares on the over-the-counter market as an observable transaction for similar securities.